Edith Canby-Hagino

Summary

Affiliation: University of Texas Health Science Center
Country: USA

Publications

  1. ncbi request reprint Local and systemic therapy for patients with metastatic prostate cancer: should the primary tumor be treated?
    Edith D Canby-Hagino
    Department of Urology, University of Texas Health Sciences Center, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
    Curr Urol Rep 6:183-9. 2005
  2. ncbi request reprint Mechanisms of disease: Prostate cancer--a model for cancer chemoprevention in clinical practice
    Edith D Canby-Hagino
    Department of Urology, University of Texas Health Science Center, San Antonio, TX 78229, USA
    Nat Clin Pract Oncol 2:255-61. 2005
  3. ncbi request reprint Looking back at PCPT: looking forward to new paradigms in prostate cancer screening and prevention
    Edith Canby-Hagino
    Department of Urology, University of Texas Health Science Center at San Antonio, TX 78229, USA
    Eur Urol 51:27-33. 2007
  4. ncbi request reprint Chemoprevention of prostate cancer with finasteride
    Edith D Canby-Hagino
    Department of Urology, University of Texas Health Science Center, San Antonio, TX 78229, USA
    Expert Opin Pharmacother 7:899-905. 2006
  5. ncbi request reprint Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial
    Ian M Thompson
    Department of Urology, University of Texas Health Science Center at San Antonio, MC 7845, 7703 Floyd Curl Dr, San Antonio, TX 78229 3900, USA
    JAMA 296:2329-35. 2006
  6. ncbi request reprint Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794
    Gregory P Swanson
    Department of Radiation Oncology and Urology, University of Texas Health Science Center, San Antonio, TX 78229 3900, USA
    J Clin Oncol 25:2225-9. 2007
  7. ncbi request reprint Association of polymorphisms in TGFB1 and prostate cancer prognosis
    Timothy C Brand
    Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas
    J Urol 179:754-8. 2008
  8. pmc The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation: data from Southwest Oncology Group 8794
    Gregory P Swanson
    University of Texas Health Science Center, San Antonio, Texas 78229 3900, USA
    J Urol 180:2453-7; discussion 2458. 2008
  9. ncbi request reprint External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population
    Dipen J Parekh
    Department of Urology, University of Texas Health Science Center, San Antonio, Texas 78229, USA
    Urology 68:1152-5. 2006
  10. ncbi request reprint Prostate cancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mL
    Edith Canby-Hagino
    Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
    Urology 70:748-52. 2007

Detail Information

Publications22

  1. ncbi request reprint Local and systemic therapy for patients with metastatic prostate cancer: should the primary tumor be treated?
    Edith D Canby-Hagino
    Department of Urology, University of Texas Health Sciences Center, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
    Curr Urol Rep 6:183-9. 2005
    ..This evidence is examined and recommendations are made for identifying patients with metastatic prostate cancer who may benefit from definitive treatment of the prostate tumor...
  2. ncbi request reprint Mechanisms of disease: Prostate cancer--a model for cancer chemoprevention in clinical practice
    Edith D Canby-Hagino
    Department of Urology, University of Texas Health Science Center, San Antonio, TX 78229, USA
    Nat Clin Pract Oncol 2:255-61. 2005
    ..Development of an effective chemoprevention strategy for prostate cancer is evolving and will likely serve as a model for chemoprevention of other adult malignancies...
  3. ncbi request reprint Looking back at PCPT: looking forward to new paradigms in prostate cancer screening and prevention
    Edith Canby-Hagino
    Department of Urology, University of Texas Health Science Center at San Antonio, TX 78229, USA
    Eur Urol 51:27-33. 2007
    ..Provide a critical summary of the latest interpretation of findings from the Prostate Cancer Prevention Trial (PCPT)...
  4. ncbi request reprint Chemoprevention of prostate cancer with finasteride
    Edith D Canby-Hagino
    Department of Urology, University of Texas Health Science Center, San Antonio, TX 78229, USA
    Expert Opin Pharmacother 7:899-905. 2006
    ..Development of a cost-effective chemoprevention strategy for prostate cancer is evolving, and is expected to have significant positive economic and public health benefits...
  5. ncbi request reprint Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial
    Ian M Thompson
    Department of Urology, University of Texas Health Science Center at San Antonio, MC 7845, 7703 Floyd Curl Dr, San Antonio, TX 78229 3900, USA
    JAMA 296:2329-35. 2006
    ..However, the optimal management of these patients after radical prostatectomy is unknown...
  6. ncbi request reprint Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794
    Gregory P Swanson
    Department of Radiation Oncology and Urology, University of Texas Health Science Center, San Antonio, TX 78229 3900, USA
    J Clin Oncol 25:2225-9. 2007
    ..In this analysis, we stratified patients as to their preradiation PSA levels and correlated it with outcomes such as PSA treatment failure, local recurrence, and distant failure, to serve as guidelines for future research...
  7. ncbi request reprint Association of polymorphisms in TGFB1 and prostate cancer prognosis
    Timothy C Brand
    Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas
    J Urol 179:754-8. 2008
    ..Because of the role of TGFB1 in prostate cancer and progression, we hypothesized that polymorphisms of TGFB1 at C-509T may be associated with prostate cancer risk and/or more aggressive tumors...
  8. pmc The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation: data from Southwest Oncology Group 8794
    Gregory P Swanson
    University of Texas Health Science Center, San Antonio, Texas 78229 3900, USA
    J Urol 180:2453-7; discussion 2458. 2008
    ..From the randomized study Southwest Oncology Group 8794 we evaluated the effect of seminal vesicle involvement on outcomes and whether those patients benefited from post-prostatectomy adjuvant radiation therapy...
  9. ncbi request reprint External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population
    Dipen J Parekh
    Department of Urology, University of Texas Health Science Center, San Antonio, Texas 78229, USA
    Urology 68:1152-5. 2006
    ....
  10. ncbi request reprint Prostate cancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mL
    Edith Canby-Hagino
    Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
    Urology 70:748-52. 2007
    ..We assessed the risk of prostate cancer in men with a positive family history (at least one first-degree or second-degree relative), normal digital rectal examination (DRE) and a serum prostate-specific antigen (PSA) level of 4.0 ng/mL...
  11. ncbi request reprint Testosterone replacement therapy and prostate cancer: a word of caution
    Timothy C Brand
    Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
    Curr Urol Rep 8:185-9. 2007
    ..A prospective evaluation of prostate cancer risk with testosterone replacement therapy has not been conducted. We outline concerns and recommendations for the use of testosterone replacement therapy in the aging man...
  12. ncbi request reprint Screening for prostate cancer: opportunities and challenges
    Ian M Thompson
    Department of Urology, University of Texas Health Science Center at San Antonio, TX 78229, USA
    Surg Oncol Clin N Am 14:747-60. 2005
    ....
  13. ncbi request reprint Biomarkers for the detection and prognosis of prostate cancer
    Javier Hernandez
    Department of Urology, University of Texas Health Sciences Center, A7703, Floyd Curl Drive, San Antonio, TX 78229, USA
    Curr Urol Rep 6:171-6. 2005
    ..In this review, we highlight some of these ongoing efforts. Proper validation of newly discovered biomarkers is of paramount importance...
  14. ncbi request reprint Prostate cancer detection strategies
    Timothy C Brand
    Department of Urology, University of Texas Health Science Center, Mail Code 7845, 7703 Floyd Curl Drive, San Antonio, TX 78229 3900, USA
    Curr Urol Rep 7:181-5. 2006
    ..Prevention strategies may be employed for higher-risk patients, and these strategies eventually may be tailored to genetic or other risks...
  15. ncbi request reprint Prognostic features in men who died of prostate cancer
    Kadee E Thompson
    Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA
    J Urol 174:553-6; discussion 556. 2005
    ..Treatment decision planning is generally linked to prognostic variables, most notably PSA, clinical stage and Gleason grade. We examined these and other prognostic variables in a cohort of men who ultimately died of prostate cancer...
  16. doi request reprint Semaphorin 3B and 3F single nucleotide polymorphisms are associated with prostate cancer risk and poor prognosis
    Joke Beuten
    Department of Cellular and Structural Biology, University of Texas Health Science Center, San Antonio, Texas 78229 3900, USA
    J Urol 182:1614-20. 2009
    ..Each gene has a single nucleotide polymorphism that results in a nonsynonymous coding change, rs2071203 (SEMA3B) and rs1046956 (SEMA3F), as well as noncoding single nucleotide polymorphisms...
  17. pmc Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial
    Ian M Thompson
    University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
    J Urol 181:956-62. 2009
    ..Extraprostatic disease will be manifest in a third of men after radical prostatectomy. We present the long-term followup of a randomized clinical trial of radiotherapy to reduce the risk of subsequent metastatic disease and death...
  18. ncbi request reprint Erectile function outcome reporting after clinically localized prostate cancer treatment
    Arthur L Burnett
    The Johns Hopkins Hospital, 600 North Wolfe St, Marburg 407, Baltimore, Maryland 21287 2411, USA
    J Urol 178:597-601. 2007
    ....
  19. ncbi request reprint Guideline for the management of clinically localized prostate cancer: 2007 update
    Ian Thompson
    American Urological Association Education and Research, Inc
    J Urol 177:2106-31. 2007
  20. doi request reprint Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy
    Carol M Moinpour
    Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    J Clin Oncol 26:112-20. 2008
    ..To compare short- and long-term effects of adjuvant treatment versus observation after surgery on health-related quality of life (HRQL) of prostate cancer patients...
  21. ncbi request reprint Chemoprevention of prostate cancer
    Timothy C Brand
    University of Texas Health Science Center, San Antonio, TX 78229, USA
    Hematol Oncol Clin North Am 20:831-43. 2006
    ..Ultimately, the goal of prostate can-cer prevention is to (1) identify men who are destined to develop clinically significant prostate cancer, and (2) provide individualized agents to prevent disease development...
  22. ncbi request reprint Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the re
    Michael S Cookson
    Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    J Urol 177:540-5. 2007
    ....